Skip to main content

DHT and Hair Loss: How the Hormone Shrinks Follicles

What is DHT and how does it cause hair loss?

You don't lose your hair because your body makes too much testosterone. You lose it because a small amount of a converted, far stronger androgen lands on follicles that happen to read the signal too strongly, and every growth cycle rebuilds the hair a little smaller than the one before it. That slow shrinking, not the sudden death of a follicle, is what you're actually watching happen in the mirror.

  1. Conversion: An enzyme strips a double bond off testosterone and turns it into a much stronger androgen.
  2. Binding: The new hormone grips the androgen receptor about four times tighter and lets go roughly three times slower.
  3. Signal change: In the dermal papilla at the base of the follicle, the bound receptor switches which genes run.
  4. Shortened growth: The active growing phase gets cut, and the resting gap between hairs gets longer.
  5. Miniaturization: Each cycle builds a finer, shorter, lighter hair until only wispy vellus hair or nothing is left.
The Bottom Line

DHT drives pattern hair loss by binding androgen receptors in the dermal papilla with roughly four times the affinity of testosterone, shortening each growth cycle until the follicle rebuilds itself smaller and finally produces only vellus hair.

What is dihydrotestosterone and how is it produced in the body?

Most people picture a hormone that gets pumped into the blood and travels to the scalp, and that picture is wrong in a way that matters. Your gonads barely release this one at all. It's built on site, inside the tissue it acts on, which is why a normal blood panel tells you far less about your hairline than you'd hope.

  • Metabolite, not a secretion: Made from testosterone by an enzyme, never released in bulk by the gonads.
  • Serum share: Blood levels run roughly a tenth of testosterone levels in an adult man.
  • Local manufacture: Skin, sebaceous glands, prostate, genital tissue and hair follicles build it on site.
  • Female supply: Women make it from testosterone and adrenal precursors at a fraction of male levels.
Key Fact

Dihydrotestosterone is a tissue-level metabolite of testosterone that circulates at roughly a tenth of testosterone's blood concentration, because most of the conversion that matters happens inside the target tissue itself.

Which enzyme converts testosterone into DHT and where is it active?

One enzyme family does the whole conversion, and it doesn't show up evenly around your body. Knowing which version sits where is what separates a drug that reaches your follicles from one that mostly works somewhere else.

Type I: Dominates in sebaceous glands, non-genital skin and the liver.
Adds to overall output, but it isn't the main driver at the scalp follicle.
Type II: The form that matters most for the prostate, seminal vesicles, epididymis and the hair follicle.
Follicles from the balding crown carry measurably more of this activity than follicles from the occipital fringe.
Type III: More widely spread and less well characterised, contributing in some tissues.
Worth Knowing

5-alpha-reductase performs the conversion through three isoenzymes, and the type II form concentrated in the hair follicle and prostate is the one whose absence from birth prevents pattern baldness entirely.

How does DHT bind to hair follicle receptors and shrink them?

The hair shaft itself has no say in any of this. The decisions get made in the dermal papilla, a small ball of cells at the base of the follicle that tells the surrounding matrix how fast to divide and how thick a hair to build. When the hormone reaches those cells, it doesn't cut the hair, it rewrites the instructions.

  1. Diffusion: The hormone slips through the membrane of a dermal papilla cell and finds its receptor.
  2. Activation: The receptor sheds its chaperones, changes shape, pairs with a second one and travels into the nucleus.
  3. Gene rewrite: Growth signals such as insulin-like growth factor 1 fall while inhibitors such as transforming growth factor beta 1 rise.
  4. Cycle shortening: The anagen phase that should run two to eight years drops toward a year, then months.
  5. Thinner output: Each rebuilt shaft carries less diameter and less pigment, with longer empty gaps between hairs.
Technical Verdict

DHT shrinks a follicle by binding androgen receptors in the dermal papilla and suppressing growth signals such as insulin-like growth factor 1 while raising inhibitors such as transforming growth factor beta 1, which cuts anagen from two to eight years down to months.

Why does DHT thin scalp hair while thickening hair on the face and body?

Here's the paradox that trips everyone up: the same hormone builds a thick beard and empties a crown, often on the same man in the same year. The hormone isn't the instruction, it's the trigger, and what happens next depends entirely on how the follicle it lands on was programmed before you were born.

Follicle region Response to androgen Result over time
Beard, chest, pubic Growth programme switches on Fine vellus hair converts to coarse terminal hair
Frontal and vertex scalp Same programme turns down Terminal hair miniaturizes back toward vellus
Occipital and lateral fringe Largely indifferent Density holds, which is why the horseshoe survives
The Lay of the Land

The same androgen signal thickens beard and body hair while thinning frontal and vertex scalp hair because each follicle carries a positional identity set during embryonic development, which is why fringe follicles transplanted into a bald crown keep growing there.

What role does inherited receptor sensitivity play in who loses hair?

If you've had your hormones checked and everything came back normal, that result wasn't a mistake. Sensitivity decides this, not supply, and sensitivity is mostly something you inherited. Two men with identical panels can sit in the same room with completely different hairlines.

  • Sensitivity over supply: Men who lose hair usually have androgen levels matching men who keep theirs.
  • X-linked anchor: The strongest single association sits at the androgen receptor locus on the X chromosome.
  • Polygenic reality: Genome-wide work has found well over two hundred independent risk regions across the autosomes.
  • Accelerants: Thyroid disease, nutritional deficiency, rapid weight loss, smoking and PCOS add shedding on top.
Worth Understanding

Pattern hair loss is decided by inherited follicle sensitivity rather than hormone level, and although the androgen receptor locus on the X chromosome carries the strongest single association, well over two hundred risk regions across the genome mean a father's contribution is substantial.

How long does miniaturization take from first thinning to a follicle that no longer grows hair?

This process moves at the speed of the hair cycle, and that cycle is slow. Your follicle only gets a handful of chances per decade to rebuild itself smaller, so the slide plays out over years. Your perception lags the biology badly, which is why so many people start treatment a decade after it began.

Anagen: 2 to 8 years Catagen: about 2 weeks Telogen: 2 to 3 months Anagen under 1 year: hair can't reach visible length Fair read on treatment: 6 to 12 months
Built to Last

Miniaturization advances at the pace of the hair cycle, so a follicle rebuilds itself smaller only a handful of times per decade and the slide from first thinning to vellus-only growth unfolds over years rather than weeks.

What useful functions does DHT serve that make suppressing it a tradeoff?

Before you decide to lower this hormone, be clear about what else it's doing. It's working hard everywhere except your scalp, and blocking its production doesn't stay in one place. That's the honest frame for the conversation, and it's a risk and benefit call you make with a clinician rather than a default.

  • Sexual function: It supports libido and erectile function alongside testosterone throughout adult life.
  • Skin and tissue: It drives sebum production, beard and body hair, and sustains prostate tissue.
  • Reported side effects: Roughly one to two percent of men report sexual side effects on type II inhibitors.
  • Systemic reach: Blocking production lowers the hormone body-wide, not just in scalp tissue.
Authority Warning

Because this hormone shapes genital development in a fetus, suppressing drugs carry an absolute contraindication in pregnancy, and they also lower prostate-specific antigen, so any PSA result reads falsely reassuring unless you tell the clinician you're taking one.

How is DHT driven hair loss told apart from other causes of shedding?

Pattern plus tempo is what separates these, and getting it wrong costs you time you can't buy back. Two processes often run together, so heavy sudden shedding on a scalp that was already thinning slowly deserves a proper look rather than an assumption.

Gradual loss with hairs of different thickness side by side: That calibre variation across the temples, vertex and mid-scalp is the androgen-driven pattern, and a dermatoscope makes it obvious.
Heavy diffuse shedding two to four months after a trigger: Uniform hair thickness points to telogen effluvium after illness, surgery, childbirth, a crash diet or severe stress.
Smooth round patches with short tapered hairs at the border: That's alopecia areata, an autoimmune attack rather than a hormonal one.
Redness, scaling, itch, burning or lost pore openings: Treat a possible scarring alopecia as urgent, because destroyed follicular openings never come back.
Head-to-Head Verdict

Androgen-driven loss is identified by pattern plus tempo, showing hairs of visibly different thickness within one small patch of scalp, while telogen effluvium sheds uniformly thick hair diffusely two to four months after a trigger.

Can a blood test or scalp examination confirm DHT is behind a person's hair loss?

If you're hoping for a number that settles it, there isn't one. The hormone doing the damage is made and used up inside your scalp, so what's circulating in your blood doesn't track what's happening at the follicle. Blood work still earns its place, just for a different job than you'd expect.

  1. Clinical pattern and history: The map of the loss plus family history carries most of the diagnosis.
  2. Trichoscopy: Shaft diameter diversity above about twenty percent, more vellus hairs, more single-hair follicular units.
  3. Blood work for mimics: Ferritin, thyroid panel, full blood count, plus an androgen panel where the history suggests it.
  4. Punch biopsy when it doesn't fit: Reserved for suspected scarring or atypical loss, settling the terminal to vellus ratio.
  5. Standardised photos: Same lighting and position, repeated at six and twelve months, to track real progress.
Best Practice

No blood test can confirm DHT as the cause, because the hormone is manufactured and consumed inside the scalp itself, so the diagnosis rests on the pattern of loss, the history and trichoscopy findings such as hair shaft diameter diversity above about twenty percent.

Daniel Zengel
Written by Daniel Zengel
Medical Writer
Daniel Zengel is the principal owner of H-Shot and a medical writer covering platelet-rich plasma and hair restoration. He draws on more than a decade in pharmaceutical and medical device roles, with a focus on regenerative medicine and the device standards and provider training that make PRP results consistent from clinic to clinic.